Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
91.20
-1.38 (-1.49%)
At close: Mar 6, 2026, 4:00 PM EST
93.03
+1.83 (2.01%)
After-hours: Mar 6, 2026, 7:16 PM EST
Guardant Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 982.02 | 739.02 | 563.95 | 449.54 | 373.65 | Upgrade
|
| Revenue Growth (YoY) | 32.88% | 31.04% | 25.45% | 20.31% | 30.31% | Upgrade
|
| Cost of Revenue | 349.01 | 289.8 | 227.05 | 156.33 | 122.91 | Upgrade
|
| Gross Profit | 633.01 | 449.22 | 336.9 | 293.21 | 250.74 | Upgrade
|
| Selling, General & Admin | 705.12 | 544.05 | 450.92 | 463.78 | 398.52 | Upgrade
|
| Research & Development | 364.19 | 347.75 | 367.19 | 373.81 | 263.22 | Upgrade
|
| Operating Expenses | 1,069 | 891.8 | 818.11 | 837.59 | 661.74 | Upgrade
|
| Operating Income | -436.3 | -442.58 | -481.22 | -544.38 | -411 | Upgrade
|
| Interest Expense | -3.9 | -2.58 | -2.58 | -2.58 | -2.58 | Upgrade
|
| Interest & Investment Income | 34.1 | 53.69 | 35.37 | 6.07 | 3.93 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.09 | 1.8 | 2.52 | -99.51 | 0.18 | Upgrade
|
| EBT Excluding Unusual Items | -398.01 | -389.68 | -445.91 | -640.4 | -409.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | -18.58 | -44.4 | 50.66 | -13.05 | - | Upgrade
|
| Legal Settlements | - | - | -83.4 | - | - | Upgrade
|
| Other Unusual Items | -0.95 | -1.01 | -0.11 | - | 25 | Upgrade
|
| Pretax Income | -417.54 | -435.09 | -478.76 | -653.45 | -384.47 | Upgrade
|
| Income Tax Expense | -1.26 | 1.28 | 0.69 | 1.14 | 0.3 | Upgrade
|
| Earnings From Continuing Operations | -416.28 | -436.37 | -479.45 | -654.59 | -384.77 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | -20.9 | Upgrade
|
| Net Income | -416.28 | -436.37 | -479.45 | -654.59 | -405.67 | Upgrade
|
| Net Income to Common | -416.28 | -436.37 | -479.45 | -654.59 | -405.67 | Upgrade
|
| Shares Outstanding (Basic) | 125 | 123 | 112 | 102 | 101 | Upgrade
|
| Shares Outstanding (Diluted) | 125 | 123 | 112 | 102 | 101 | Upgrade
|
| Shares Change (YoY) | 2.14% | 9.61% | 9.60% | 0.85% | 3.91% | Upgrade
|
| EPS (Basic) | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | Upgrade
|
| EPS (Diluted) | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 | Upgrade
|
| Free Cash Flow | -233.07 | -274.94 | -345.46 | -386.92 | -284.05 | Upgrade
|
| Free Cash Flow Per Share | -1.86 | -2.24 | -3.08 | -3.79 | -2.80 | Upgrade
|
| Gross Margin | 64.46% | 60.79% | 59.74% | 65.22% | 67.11% | Upgrade
|
| Operating Margin | -44.43% | -59.89% | -85.33% | -121.10% | -110.00% | Upgrade
|
| Profit Margin | -42.39% | -59.05% | -85.02% | -145.61% | -108.57% | Upgrade
|
| Free Cash Flow Margin | -23.73% | -37.20% | -61.26% | -86.07% | -76.02% | Upgrade
|
| EBITDA | -396.56 | -400.2 | -438.33 | -508.42 | -388.73 | Upgrade
|
| EBITDA Margin | -40.38% | -54.15% | -77.73% | -113.10% | -104.04% | Upgrade
|
| D&A For EBITDA | 39.74 | 42.39 | 42.88 | 35.96 | 22.27 | Upgrade
|
| EBIT | -436.3 | -442.58 | -481.22 | -544.38 | -411 | Upgrade
|
| EBIT Margin | -44.43% | -59.89% | -85.33% | -121.10% | -110.00% | Upgrade
|
| Revenue as Reported | - | - | - | 449.54 | 373.65 | Upgrade
|
| Advertising Expenses | - | - | - | - | 2.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.